CooperVision has been carefully monitoring the outbreak of the 2019 Novel Coronavirus (COVID-19). The safety of our employees, customers (both contact lens wearers and eye care professionals), partners and communities is our top priority.
There is currently no evidence to suggest that there is any increased risk of infection or contracting coronavirus through contact lens wear. Remember to follow strict hygiene measures, such as thorough handwashing, along with optimal wear and care procedures. These include replacing your lenses as prescribed, case hygiene for reusable lenses and avoiding lens wear if you are unwell (in particular with any cold or flu-like symptoms).
Avoid touching your eyes, especially in high risk environments, and remember to ask yourself these three questions each time you wear your lenses:
- Do my eyes feel good with my lenses? There should be no discomfort.
- Do my eyes look good? There should be no redness.
- Do I see well? There should be no unusual blurring with either eye.
If you have any concerns, remove your contact lenses and consult your eye care professional.
Read more about lens wear and care at https://coopervision.com/about-contacts/contact-lens-tips
CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world’s leading manufacturers of soft contact lenses. The Company produces a full array of daily disposable, two-week and monthly contact lenses, all featuring advanced materials and optics. CooperVision has a strong heritage of solving the toughest vision challenges such as astigmatism, presbyopia and childhood myopia; and offers the most complete collection of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.
Mike McDougall, APR, Fellow PRSA
McDougall Communications for CooperVision, Inc.
email@example.com or +1-585-545-1815